Adicet Bio, Inc. (ACET)

Adicet Bio Statistics

Total Valuation

Adicet Bio has a market cap or net worth of $81.56 million. The enterprise value is -$7.72 million.

Market Cap	81.56M
Enterprise Value	-7.72M

Important Dates

The next estimated earnings date is Thursday, March 5, 2026, after market close.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Adicet Bio has 10.11 million shares outstanding. The number of shares has increased by 20.10% in one year.

Current Share Class	9.58M
Shares Outstanding	10.11M
Shares Change (YoY)	+20.10%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.81%
Owned by Institutions (%)	63.72%
Float	8.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.41
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.62, with a Debt / Equity ratio of 0.14.

Current Ratio	5.62
Quick Ratio	5.45
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9,305.46

Financial Efficiency

Return on equity (ROE) is -71.73% and return on invested capital (ROIC) is -42.67%.

Return on Equity (ROE)	-71.73%
Return on Assets (ROA)	-39.13%
Return on Invested Capital (ROIC)	-42.67%
Return on Capital Employed (ROCE)	-99.53%
Revenue Per Employee	n/a
Profits Per Employee	-$756,671
Employee Count	152
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.48% in the last 52 weeks. The beta is 1.61, so Adicet Bio's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	-44.48%
50-Day Moving Average	8.75
200-Day Moving Average	10.94
Relative Strength Index (RSI)	46.36
Average Volume (20 Days)	203,367

Short Selling Information

The latest short interest is 642,724, so 6.36% of the outstanding shares have been sold short.

Short Interest	642,724
Short Previous Month	14.91M
Short % of Shares Out	6.36%
Short % of Float	7.64%
Short Ratio (days to cover)	3.30

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-120.97M
Pretax Income	-115.01M
Net Income	-115.01M
EBITDA	-114.44M
EBIT	-120.97M
Earnings Per Share (EPS)	-$20.18

Balance Sheet

The company has $103.10 million in cash and $15.54 million in debt, with a net cash position of $87.56 million or $8.66 per share.

Cash & Cash Equivalents	103.10M
Total Debt	15.54M
Net Cash	87.56M
Net Cash Per Share	$8.66
Equity (Book Value)	109.14M
Book Value Per Share	19.04
Working Capital	87.55M

Cash Flow

In the last 12 months, operating cash flow was -$98.44 million and capital expenditures -$1.92 million, giving a free cash flow of -$100.36 million.

Operating Cash Flow	-98.44M
Capital Expenditures	-1.92M
Free Cash Flow	-100.36M
FCF Per Share	-$9.93

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Adicet Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.10%
Shareholder Yield	-20.10%
Earnings Yield	-144.06%
FCF Yield	-125.70%

Analyst Forecast

The average price target for Adicet Bio is $65.33, which is 709.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$65.33
Price Target Difference	709.54%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 30, 2025. It was a reverse split with a ratio of 1:16.

Last Split Date	Dec 30, 2025
Split Type	Reverse
Split Ratio	1:16

Scores

Altman Z-Score	n/a
Piotroski F-Score	1